Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
Cancer stem cells (CSCs), also known as tumor-initiating cells (TICs), are suggested to be responsible for drug resistance and cancer relapse due in part to their ability to self-renew themselves and differentiate into heterogeneous lineages of cancer cells. Thus, it is important to understand the c...
Main Authors: | Lan Thi Hanh Phi, Ita Novita Sari, Ying-Gui Yang, Sang-Hyun Lee, Nayoung Jun, Kwang Seock Kim, Yun Kyung Lee, Hyog Young Kwon |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2018-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2018/5416923 |
Similar Items
-
Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells
by: Ita Novita Sari, et al.
Published: (2018-11-01) -
CSCs in Breast Cancer—One Size Does Not Fit All: Therapeutic Advances in Targeting Heterogeneous Epithelial and Mesenchymal CSCs
by: Andrew Sulaiman, et al.
Published: (2019-08-01) -
miR551b Regulates Colorectal Cancer Progression by Targeting the ZEB1 Signaling Axis
by: Kwang Seock Kim, et al.
Published: (2019-05-01) -
Therapeutic approach of Cancer stem cells (CSCs) in gastric adenocarcinoma; DNA methyltransferases enzymes in cancer targeted therapy
by: Syedeh Elham Norollahi, et al.
Published: (2019-07-01) -
Repurposing Established Compounds to Target Pancreatic Cancer Stem Cells (CSCs)
by: Bernhard W. Renz, et al.
Published: (2017-06-01)